Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion type Assertion NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_head.
- NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_provenance.
- NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion evidence source_evidence_literature NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_provenance.
- NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion SIO_000772 23660859 NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_provenance.
- NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion wasDerivedFrom befree-20140225 NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_provenance.
- NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion wasGeneratedBy ECO_0000203 NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_provenance.